Abbvie (ABBV) PT Lowered to $84 at Morgan Stanley
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $259.99 +1.39%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Morgan Stanley analyst David Risinger lowered the price target on Abbvie (NYSE: ABBV) to $84.00 (from $88.00) while maintaining a Equalweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Ascendis Pharma (ASND) PT Raised to $312 at Oppenheimer
- Vibra Energia SA (VBBR3:BZ) PT Raised to R$43 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
